Long-term success rates

Starting on a GLP-1, Then Surgery: The Combination Approach

Why 2026 research is treating medication and surgery as a sequence, not a rivalry

Starting on a GLP-1, Then Surgery: The Combination Approach

For years, the choice in obesity treatment was framed as a fork in the road: medication or surgery, pick a lane. In 2026, some of the most interesting research is pointing somewhere else entirely — not at a fork, but at a sequence. Start with one tool, then add the other.

The idea of beginning on a GLP-1 medication and later having bariatric surgery is gaining real ground, and it's worth understanding whether you're just starting out or already have a prescription in your medicine cabinet.

Two tools, not two teams

The public conversation loves a rivalry — Ozempic versus the operating room. But that framing was never quite right. GLP-1 medications and bariatric surgery both work on the same underlying biology: the hormones that control hunger, fullness, and how stubbornly your body holds onto weight. They just do it in different ways and to different degrees.

Once you see them as two tools that act on the same system, the interesting question stops being "which one wins?" and becomes "is there a smart order to use them in?" For a growing number of people, the answer is turning out to be yes.

The sequencing logic

The reasoning behind starting with medication and finishing with surgery is fairly intuitive once you lay it out.

A GLP-1 can help you lose an initial chunk of weight and improve your overall health before an operation. Entering surgery lighter and healthier can make the procedure safer and recovery smoother. It can also build momentum and confidence — proof to yourself that change is possible — before taking the bigger step.

Then surgery does what surgery does best: deliver a larger, more durable result by physically changing the anatomy that drives those hunger and fullness signals, rather than supplementing them from the outside. The medication opens the door; the surgery walks you through it and keeps it open.

What the 2026 research found

Research presented at the American Society for Metabolic and Bariatric Surgery meeting in May 2026 put some numbers behind the idea. Researchers looked at records for more than 6,700 people who started on a GLP-1 and then had surgery:1

  • Roughly 8% of body weight lost during the GLP-1 phase, before surgery.
  • Total weight loss of more than 25% with gastric bypass, or about 20% with sleeve gastrectomy, once surgery was added.

So the two phases did add up, and people ended up well ahead of where medication alone typically lands.

But here is the part that matters most, and that a lot of coverage left out. When the researchers compared these patients against roughly 127,000 people who went straight to surgery, the straight-to-surgery group actually lost 2–3% more after their operation.1 The head start from the medication didn't multiply the surgical result — it mostly just didn't get in the way.

That reframes what this research is really saying. It is good evidence that starting on a GLP-1 doesn't cost you anything at surgery — which is genuinely reassuring if you're already on one. It is not evidence that everyone should take a medication first to get a better surgical outcome.

Two more honest caveats. This was presented at a conference and has not yet been through peer review, so treat it as promising early data rather than settled fact. And it was a look back at medical records, not a trial that assigned people to one path or the other — so the two groups may have differed in ways the numbers can't fully account for.

Honest reasons it can help

Beyond the raw numbers, there are practical, human reasons a staged approach appeals to people:

  • Health before surgery. Losing some weight and improving blood sugar or blood pressure beforehand can reduce surgical risk.
  • A gentler on-ramp. Starting with a medication can feel less daunting than jumping straight to an operation, especially for someone who's scared of surgery.
  • Momentum. Early, visible progress can strengthen the resolve needed for the preparation and follow-up that surgery requires.
  • A bridge, not a dead end. For someone whose weight loss on medication stalls or plateaus, surgery offers a next step rather than a shrug.

Honest caveats

A staged approach is not automatically the right approach, and it isn't for everyone.

It's still an emerging strategy, and the details — who benefits most, the best timing, how the two phases should be managed — are being worked out. It also means going through two treatments rather than one, with the costs, effort, and adjustment that each involves. And plenty of people do very well starting directly with surgery, or staying on medication long-term without ever needing surgery. There is no single correct path here, only the one that fits a specific person.

The questions patients actually ask

If a combined approach interests you, a few practical questions come up again and again. The honest answer to most of them is "it depends, and your care team will guide you" — but it helps to know they're normal things to ask:

  • Do you stop the medication before surgery? There are standard practices around this, and they depend on the specific drug and your surgical team's protocol. It's a planned, guided step — not something to figure out on your own.
  • Will the early weight loss "count"? The point isn't a number on a chart before surgery; it's arriving healthier and safer. Your team looks at the whole trajectory.
  • What happens to the medication afterward? Some people stop it after surgery, some continue or restart it if needed. That's an individualized decision made with your doctor over time.

The theme running through all of these: a staged approach is something you do with a medical team, deliberately, not something you improvise.

Key takeaway

The old "drugs versus surgery" debate is giving way to a more useful idea: that a GLP-1 and bariatric surgery can be two stages of one plan rather than rival options. The 2026 research suggests that people who start on a medication and then have surgery end up far ahead of medication alone — and, importantly, that the medication phase doesn't compromise what surgery can do. What it does not show is that everyone should take a drug first; people who went straight to surgery did slightly better after their operation.

It's a promising, still-emerging approach, and it's deeply individual. If you're already on a GLP-1 and wondering what comes next, or just mapping out how to begin, that's exactly the conversation to bring to a qualified team — one that will help you decide not just which tool, but in what order.

References

This article was last reviewed and updated on August 26, 2026. It is general education, not medical advice — decisions about combining medication and surgery should be made with your own medical team.


  1. Chhabra KR, Kozato A, et al. (NYU Grossman School of Medicine). "Metabolic and bariatric surgery after GLP-1 treatment." Presented at the ASMBS 2026 Annual Scientific Meeting, San Antonio, May 5, 2026. ASMBS news release — Retrospective analysis of Epic Cosmos records, January 2019–March 2025. Conference abstract; preliminary findings not yet peer-reviewed. 

P
Written by
Pompeii Surgical Team

Expert contributor to Pompeii Surgical's blog, providing valuable insights on bariatric surgery and weight loss journeys.

View profile →